These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37097165)

  • 1. Histone acetylation gene-based biomarkers as novel markers of the immune microenvironment in glioblastoma.
    Yan X; Feng L; Xu Z; Chen W; Yan H; Wu P; Ding C; Zhu X; Lu Y
    J Gene Med; 2023 Oct; 25(10):e3511. PubMed ID: 37097165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi-omics approach and prognostic model development.
    Liu Z; Zhao P
    J Cell Mol Med; 2024 Apr; 28(8):e18230. PubMed ID: 38568083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
    Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
    Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of histone acetylation-related genes in glioblastoma and lower-grade gliomas: Insights into drug sensitivity, molecular subtypes, immune infiltration, and prognosis.
    Qin J; Fu J; Chen X
    J Gene Med; 2024 Mar; 26(3):e3678. PubMed ID: 38500293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
    Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
    Front Oncol; 2022; 12():938679. PubMed ID: 35982954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
    Wang D; Jiang Y; Wang T; Wang Z; Zou F
    BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
    Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
    BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
    Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
    Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients.
    Wang W; Shen Y; Zhang P; Liu L; Sha X; Li H; Wang S; Zhang H; Zhou Y; Shi J
    J Thorac Dis; 2022 Oct; 14(10):3886-3902. PubMed ID: 36389327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
    Dai L; Guo X; Xing Z; Tao Y; Liang W; Shi Z; Hu W; Zhou S; Wang X
    BMC Cancer; 2023 Jan; 23(1):102. PubMed ID: 36717836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model.
    Liu Y; Wu Z; Feng Y; Gao J; Wang B; Lian C; Diao B
    Front Oncol; 2023; 13():1109037. PubMed ID: 37397378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics approaches establishing histone modification based prognostic model in glioma patients and further verification of the carcinogenesis mechanism.
    Wang Y; Ji L; Ji C; Wang F
    Funct Integr Genomics; 2023 Sep; 23(4):307. PubMed ID: 37730879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
    Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
    Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling.
    Guo XY; Zhang GH; Wang ZN; Duan H; Xie T; Liang L; Cui R; Hu HR; Wu Y; Dong JJ; He ZQ; Mou YG
    Aging (Albany NY); 2021 Jan; 13(3):3501-3517. PubMed ID: 33429364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a prognostic model for glioblastoma multiforme based on the expression levels of efferocytosis-related genes.
    Xu W; Han L; Zhu P; Cheng Y; Chen X
    Aging (Albany NY); 2023 Dec; 15(24):15578-15598. PubMed ID: 38159261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis.
    Zhang H; Bao M; Liao D; Zhang Z; Tian Z; Yang E; Luo P; Jiang X
    Med Oncol; 2023 Apr; 40(6):161. PubMed ID: 37099121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.